High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis

Hervé Tissot-Dupont (1, 2) , Frederique Gouriet (1, 2) , Leopold Oliver (3) , Matthieu Jamme (4) , Jean-Paul Casalta (2) , Marie-Therese Jimeno (5) , Florent Arregle , Cecile Lavoute (6) , Sandrine Hubert (7) , Mary Philip , Hélène Martel , Alberto Riberi (1) , Gilbert Habib (1) , Didier Raoult (1)

1 MEPHI - Microbes évolution phylogénie et infections
2 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
3 UPEC Médecine - Université Paris-Est Créteil Val-de-Marne - Faculté de médecine
4 CHI Poissy-Saint-Germain
5 VITROME - Vecteurs - Infections tropicales et méditerranéennes
6 Département de Cardiologie [Hôpital de la Timone - APHM]
7 APHM - Assistance Publique - Hôpitaux de Marseille

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Hervé Tissot-Dupont, Frederique Gouriet, Leopold Oliver, Matthieu Jamme, Jean-Paul Casalta, et al.. High-dose trimethoprim-sulfamethoxazole and clindamycin for Staphylococcus aureus endocarditis. International Journal of Antimicrobial Agents, 2019, 54 (2), pp.143-148. ⟨10.1016/j.ijantimicag.2019.06.006⟩. ⟨hal-02465226⟩